• Medpace: President and CEO August J. Troendle sold 4,673 common shares on Aug. 25-26.
• Sales priced at USD 620.38, USD 620.03; direct holdings fell to 540,544 shares.
• Indirect stake held via Medpace Investors totaled 4.73 million shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001622058-26-000008), on August 27, 2026, and is solely responsible for the information contained therein.